关于痛风药物治疗的最新情况
Jack Shi Jie Yuan1,2, Anush Shashidhara2, Aman Sutaria3
1Department of Rheumatology, Royal Free London NHS Foundation Trust, London, UK.
Expert opinion on pharmacotherapy
|December 12, 2024
概括
痛风管理包括治疗急性发作,使用诸如胆固醇或NSAIDs之类的选择,并通过药物降低尿酸水平,如Allopurinol. 个性化治疗计划对于有效的痛风护理至关重要.
科学领域:
- 类风湿病学 类风湿病学
- 临床药理学 临床药理学
背景情况:
- 痛风是一种普遍的炎症性关节炎,由单酸盐晶体沉积引起.
- 结晶积累导致严重的关节疼痛,严重影响患者的生活质量.
研究的目的:
- 审查当前的痛风治疗策略,包括急性发作管理和尿酸降低疗法.
- 根据国际指导方针,讨论新兴的痛风疗法和个性化治疗方法.
主要方法:
- 主要国际社会关于痛风治疗指南的文献综述.
- 针对急性痛风爆发和慢性治疗的既定和新型药物疗法的摘要.
主要成果:
- 对于耐火病例,急性发作可以用胆固醇,NSAID,皮质类固醇或IL-1抑制剂治疗.
- 尿酸降低疗法 (例如,阿洛普林醇,费布克斯托特) 使用治疗到目标的策略来降低血清尿酸.
- 个性化药理疗考虑了慢性病等并发症以及患者的偏好.
结论:
- 目前的痛风治疗强调迅速的发作管理和持续的尿酸降低.
- 新兴的疗法和个性化方法正在推动痛风管理.
- 遵守指导方针和个性化护理优化了痛风患者的治疗结果.
相关概念视频
01:26Peptic Ulcer Disease IV: Management
72
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
72
01:16Antihypertensive Drugs: Action of Diuretics
618
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
618
01:28Drug Therapy
39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
39
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
468
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
468
01:24Phase II Reactions: Glucuronidation
287
Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
287
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
385
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
385